img

Global Tianeptine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tianeptine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Tianeptine, sold under the brand names Stablon and Coaxil among others, is an atypical antidepressant which is used mainly in the treatment of major depressive disorder, although it may also be used to treat anxiety, asthma, and irritable bowel syndrome.
Tianeptine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Tianeptine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Depression and Anxiety and Irritable Bowel Syndrome are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Tianeptine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Tianeptine key manufacturers include Servier, Lupin Limited, PharmaS, Antibiotice, Serdia Pharmaceuticals, Alvogen, Bausch Health, Genefar B.V. and Arena Pharmaceuticals, etc. Servier, Lupin Limited, PharmaS are top 3 players and held % sales share in total in 2022.
Tianeptine can be divided into Patent and Generic, etc. Patent is the mainstream product in the market, accounting for % sales share globally in 2022.
Tianeptine is widely used in various fields, such as Depression and Anxiety and Irritable Bowel Syndrome, etc. Depression and Anxiety provides greatest supports to the Tianeptine industry development. In 2022, global % sales of Tianeptine went into Depression and Anxiety filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Tianeptine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Servier
Lupin Limited
PharmaS
Antibiotice
Serdia Pharmaceuticals
Alvogen
Bausch Health
Genefar B.V.
Arena Pharmaceuticals
Glenmark
Novartis
Dongwha Pharm
Liconsa SA
Mylan
Adamed
Neuraxpharm Arzneimittel
Grupo Insud
Segment by Type
Patent
Generic

Segment by Application


Depression and Anxiety
Irritable Bowel Syndrome

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Tianeptine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Tianeptine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Tianeptine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Tianeptine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Tianeptine introduction, etc. Tianeptine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Tianeptine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Tianeptine Market Overview
1.1 Tianeptine Product Overview
1.2 Tianeptine Market Segment by Type
1.2.1 Patent
1.2.2 Generic
1.3 Global Tianeptine Market Size by Type
1.3.1 Global Tianeptine Market Size Overview by Type (2024-2034)
1.3.2 Global Tianeptine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Tianeptine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tianeptine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Tianeptine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Tianeptine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Tianeptine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Tianeptine Sales Breakdown by Type (2024-2024)
2 Global Tianeptine Market Competition by Company
2.1 Global Top Players by Tianeptine Sales (2024-2024)
2.2 Global Top Players by Tianeptine Revenue (2024-2024)
2.3 Global Top Players by Tianeptine Price (2024-2024)
2.4 Global Top Manufacturers Tianeptine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tianeptine Market Competitive Situation and Trends
2.5.1 Tianeptine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Tianeptine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tianeptine as of 2022)
2.7 Date of Key Manufacturers Enter into Tianeptine Market
2.8 Key Manufacturers Tianeptine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tianeptine Status and Outlook by Region
3.1 Global Tianeptine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Tianeptine Historic Market Size by Region
3.2.1 Global Tianeptine Sales in Volume by Region (2024-2024)
3.2.2 Global Tianeptine Sales in Value by Region (2024-2024)
3.2.3 Global Tianeptine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Tianeptine Forecasted Market Size by Region
3.3.1 Global Tianeptine Sales in Volume by Region (2024-2034)
3.3.2 Global Tianeptine Sales in Value by Region (2024-2034)
3.3.3 Global Tianeptine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Tianeptine by Application
4.1 Tianeptine Market Segment by Application
4.1.1 Depression and Anxiety
4.1.2 Irritable Bowel Syndrome
4.2 Global Tianeptine Market Size by Application
4.2.1 Global Tianeptine Market Size Overview by Application (2024-2034)
4.2.2 Global Tianeptine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Tianeptine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tianeptine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Tianeptine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Tianeptine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Tianeptine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Tianeptine Sales Breakdown by Application (2024-2024)
5 North America Tianeptine by Country
5.1 North America Tianeptine Historic Market Size by Country
5.1.1 North America Tianeptine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Tianeptine Sales in Volume by Country (2024-2024)
5.1.3 North America Tianeptine Sales in Value by Country (2024-2024)
5.2 North America Tianeptine Forecasted Market Size by Country
5.2.1 North America Tianeptine Sales in Volume by Country (2024-2034)
5.2.2 North America Tianeptine Sales in Value by Country (2024-2034)
6 Europe Tianeptine by Country
6.1 Europe Tianeptine Historic Market Size by Country
6.1.1 Europe Tianeptine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Tianeptine Sales in Volume by Country (2024-2024)
6.1.3 Europe Tianeptine Sales in Value by Country (2024-2024)
6.2 Europe Tianeptine Forecasted Market Size by Country
6.2.1 Europe Tianeptine Sales in Volume by Country (2024-2034)
6.2.2 Europe Tianeptine Sales in Value by Country (2024-2034)
7 Asia-Pacific Tianeptine by Region
7.1 Asia-Pacific Tianeptine Historic Market Size by Region
7.1.1 Asia-Pacific Tianeptine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Tianeptine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Tianeptine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Tianeptine Forecasted Market Size by Region
7.2.1 Asia-Pacific Tianeptine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Tianeptine Sales in Value by Region (2024-2034)
8 Latin America Tianeptine by Country
8.1 Latin America Tianeptine Historic Market Size by Country
8.1.1 Latin America Tianeptine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Tianeptine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Tianeptine Sales in Value by Country (2024-2024)
8.2 Latin America Tianeptine Forecasted Market Size by Country
8.2.1 Latin America Tianeptine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Tianeptine Sales in Value by Country (2024-2034)
9 Middle East and Africa Tianeptine by Country
9.1 Middle East and Africa Tianeptine Historic Market Size by Country
9.1.1 Middle East and Africa Tianeptine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Tianeptine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Tianeptine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Tianeptine Forecasted Market Size by Country
9.2.1 Middle East and Africa Tianeptine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Tianeptine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Servier
10.1.1 Servier Company Information
10.1.2 Servier Introduction and Business Overview
10.1.3 Servier Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Servier Tianeptine Products Offered
10.1.5 Servier Recent Development
10.2 Lupin Limited
10.2.1 Lupin Limited Company Information
10.2.2 Lupin Limited Introduction and Business Overview
10.2.3 Lupin Limited Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Lupin Limited Tianeptine Products Offered
10.2.5 Lupin Limited Recent Development
10.3 PharmaS
10.3.1 PharmaS Company Information
10.3.2 PharmaS Introduction and Business Overview
10.3.3 PharmaS Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 PharmaS Tianeptine Products Offered
10.3.5 PharmaS Recent Development
10.4 Antibiotice
10.4.1 Antibiotice Company Information
10.4.2 Antibiotice Introduction and Business Overview
10.4.3 Antibiotice Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Antibiotice Tianeptine Products Offered
10.4.5 Antibiotice Recent Development
10.5 Serdia Pharmaceuticals
10.5.1 Serdia Pharmaceuticals Company Information
10.5.2 Serdia Pharmaceuticals Introduction and Business Overview
10.5.3 Serdia Pharmaceuticals Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Serdia Pharmaceuticals Tianeptine Products Offered
10.5.5 Serdia Pharmaceuticals Recent Development
10.6 Alvogen
10.6.1 Alvogen Company Information
10.6.2 Alvogen Introduction and Business Overview
10.6.3 Alvogen Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Alvogen Tianeptine Products Offered
10.6.5 Alvogen Recent Development
10.7 Bausch Health
10.7.1 Bausch Health Company Information
10.7.2 Bausch Health Introduction and Business Overview
10.7.3 Bausch Health Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Bausch Health Tianeptine Products Offered
10.7.5 Bausch Health Recent Development
10.8 Genefar B.V.
10.8.1 Genefar B.V. Company Information
10.8.2 Genefar B.V. Introduction and Business Overview
10.8.3 Genefar B.V. Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Genefar B.V. Tianeptine Products Offered
10.8.5 Genefar B.V. Recent Development
10.9 Arena Pharmaceuticals
10.9.1 Arena Pharmaceuticals Company Information
10.9.2 Arena Pharmaceuticals Introduction and Business Overview
10.9.3 Arena Pharmaceuticals Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Arena Pharmaceuticals Tianeptine Products Offered
10.9.5 Arena Pharmaceuticals Recent Development
10.10 Glenmark
10.10.1 Glenmark Company Information
10.10.2 Glenmark Introduction and Business Overview
10.10.3 Glenmark Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Glenmark Tianeptine Products Offered
10.10.5 Glenmark Recent Development
10.11 Novartis
10.11.1 Novartis Company Information
10.11.2 Novartis Introduction and Business Overview
10.11.3 Novartis Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Novartis Tianeptine Products Offered
10.11.5 Novartis Recent Development
10.12 Dongwha Pharm
10.12.1 Dongwha Pharm Company Information
10.12.2 Dongwha Pharm Introduction and Business Overview
10.12.3 Dongwha Pharm Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Dongwha Pharm Tianeptine Products Offered
10.12.5 Dongwha Pharm Recent Development
10.13 Liconsa SA
10.13.1 Liconsa SA Company Information
10.13.2 Liconsa SA Introduction and Business Overview
10.13.3 Liconsa SA Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Liconsa SA Tianeptine Products Offered
10.13.5 Liconsa SA Recent Development
10.14 Mylan
10.14.1 Mylan Company Information
10.14.2 Mylan Introduction and Business Overview
10.14.3 Mylan Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Mylan Tianeptine Products Offered
10.14.5 Mylan Recent Development
10.15 Adamed
10.15.1 Adamed Company Information
10.15.2 Adamed Introduction and Business Overview
10.15.3 Adamed Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Adamed Tianeptine Products Offered
10.15.5 Adamed Recent Development
10.16 Neuraxpharm Arzneimittel
10.16.1 Neuraxpharm Arzneimittel Company Information
10.16.2 Neuraxpharm Arzneimittel Introduction and Business Overview
10.16.3 Neuraxpharm Arzneimittel Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Neuraxpharm Arzneimittel Tianeptine Products Offered
10.16.5 Neuraxpharm Arzneimittel Recent Development
10.17 Grupo Insud
10.17.1 Grupo Insud Company Information
10.17.2 Grupo Insud Introduction and Business Overview
10.17.3 Grupo Insud Tianeptine Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Grupo Insud Tianeptine Products Offered
10.17.5 Grupo Insud Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tianeptine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tianeptine Industrial Chain Analysis
11.4 Tianeptine Market Dynamics
11.4.1 Tianeptine Industry Trends
11.4.2 Tianeptine Market Drivers
11.4.3 Tianeptine Market Challenges
11.4.4 Tianeptine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tianeptine Distributors
12.3 Tianeptine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Patent
Table 2. Major Company of Generic
Table 3. Global Tianeptine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Tianeptine Sales by Type (2024-2024) & (K Units)
Table 5. Global Tianeptine Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Tianeptine Sales by Type (2024-2024) & (US& Million)
Table 7. Global Tianeptine Market Share in Value by Type (2024-2024)
Table 8. Global Tianeptine Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Tianeptine Sales by Type (2024-2034) & (K Units)
Table 10. Global Tianeptine Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Tianeptine Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Tianeptine Sales Market Share in Value by Type (2024-2034)
Table 13. Global Tianeptine Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Tianeptine Sales by Type (2024-2024) & (K Units)
Table 15. North America Tianeptine Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Tianeptine Sales (K Units) by Type (2024-2024)
Table 17. Europe Tianeptine Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Tianeptine Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Tianeptine Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Tianeptine Sales (K Units) by Type (2024-2024)
Table 21. Latin America Tianeptine Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Tianeptine Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Tianeptine Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Tianeptine Sales by Company (2024-2024) & (K Units)
Table 25. Global Tianeptine Sales Share by Company (2024-2024)
Table 26. Global Tianeptine Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Tianeptine Revenue Share by Company (2024-2024)
Table 28. Global Market Tianeptine Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Tianeptine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Tianeptine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tianeptine as of 2022)
Table 32. Date of Key Manufacturers Enter into Tianeptine Market
Table 33. Key Manufacturers Tianeptine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Tianeptine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Tianeptine Sales by Region (2024-2024) & (K Units)
Table 37. Global Tianeptine Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Tianeptine Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Tianeptine Sales Market Share in Value by Region (2024-2024)
Table 40. Global Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Tianeptine Sales by Region (2024-2034) & (K Units)
Table 42. Global Tianeptine Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Tianeptine Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Tianeptine Sales Market Share in Value by Region (2024-2034)
Table 45. Global Tianeptine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Tianeptine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Tianeptine Sales by Application (2024-2024) & (K Units)
Table 48. Global Tianeptine Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Tianeptine Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Tianeptine Sales Market Share in Value by Application (2024-2024)
Table 51. Global Tianeptine Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Tianeptine Sales by Application (2024-2034) & (K Units)
Table 53. Global Tianeptine Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Tianeptine Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Tianeptine Sales Market Share in Value by Application (2024-2034)
Table 56. Global Tianeptine Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Tianeptine Sales by Application (2024-2024) (K Units)
Table 58. North America Tianeptine Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Tianeptine Sales by Application (2024-2024) (K Units)
Table 60. Europe Tianeptine Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Tianeptine Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Tianeptine Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Tianeptine Sales by Application (2024-2024) (K Units)
Table 64. Latin America Tianeptine Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Tianeptine Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Tianeptine Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Tianeptine Sales by Country (2024-2024) & (K Units)
Table 68. North America Tianeptine Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Tianeptine Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Tianeptine Sales Market Share in Value by Country (2024-2024)
Table 71. North America Tianeptine Sales by Country (2024-2034) & (K Units)
Table 72. North America Tianeptine Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Tianeptine Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Tianeptine Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Tianeptine Sales by Country (2024-2024) & (K Units)
Table 76. Europe Tianeptine Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Tianeptine Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Tianeptine Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Tianeptine Sales by Country (2024-2034) & (K Units)
Table 80. Europe Tianeptine Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Tianeptine Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Tianeptine Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Tianeptine Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Tianeptine Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Tianeptine Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Tianeptine Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Tianeptine Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Tianeptine Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Tianeptine Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Tianeptine Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Tianeptine Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Tianeptine Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Tianeptine Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Tianeptine Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Tianeptine Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Tianeptine Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Tianeptine Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Tianeptine Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Tianeptine Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Tianeptine Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Tianeptine Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Tianeptine Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Tianeptine Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Tianeptine Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Tianeptine Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Tianeptine Sales Market Share in Value by Country (2024-2034)
Table 107. Servier Company Information
Table 108. Servier Introduction and Business Overview
Table 109. Servier Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Servier Tianeptine Product
Table 111. Servier Recent Development
Table 112. Lupin Limited Company Information
Table 113. Lupin Limited Introduction and Business Overview
Table 114. Lupin Limited Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Lupin Limited Tianeptine Product
Table 116. Lupin Limited Recent Development
Table 117. PharmaS Company Information
Table 118. PharmaS Introduction and Business Overview
Table 119. PharmaS Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. PharmaS Tianeptine Product
Table 121. PharmaS Recent Development
Table 122. Antibiotice Company Information
Table 123. Antibiotice Introduction and Business Overview
Table 124. Antibiotice Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Antibiotice Tianeptine Product
Table 126. Antibiotice Recent Development
Table 127. Serdia Pharmaceuticals Company Information
Table 128. Serdia Pharmaceuticals Introduction and Business Overview
Table 129. Serdia Pharmaceuticals Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Serdia Pharmaceuticals Tianeptine Product
Table 131. Serdia Pharmaceuticals Recent Development
Table 132. Alvogen Company Information
Table 133. Alvogen Introduction and Business Overview
Table 134. Alvogen Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Alvogen Tianeptine Product
Table 136. Alvogen Recent Development
Table 137. Bausch Health Company Information
Table 138. Bausch Health Introduction and Business Overview
Table 139. Bausch Health Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Bausch Health Tianeptine Product
Table 141. Bausch Health Recent Development
Table 142. Genefar B.V. Company Information
Table 143. Genefar B.V. Introduction and Business Overview
Table 144. Genefar B.V. Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Genefar B.V. Tianeptine Product
Table 146. Genefar B.V. Recent Development
Table 147. Arena Pharmaceuticals Company Information
Table 148. Arena Pharmaceuticals Introduction and Business Overview
Table 149. Arena Pharmaceuticals Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Arena Pharmaceuticals Tianeptine Product
Table 151. Arena Pharmaceuticals Recent Development
Table 152. Glenmark Company Information
Table 153. Glenmark Introduction and Business Overview
Table 154. Glenmark Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Glenmark Tianeptine Product
Table 156. Glenmark Recent Development
Table 157. Novartis Company Information
Table 158. Novartis Introduction and Business Overview
Table 159. Novartis Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Novartis Tianeptine Product
Table 161. Novartis Recent Development
Table 162. Dongwha Pharm Company Information
Table 163. Dongwha Pharm Introduction and Business Overview
Table 164. Dongwha Pharm Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Dongwha Pharm Tianeptine Product
Table 166. Dongwha Pharm Recent Development
Table 167. Liconsa SA Company Information
Table 168. Liconsa SA Introduction and Business Overview
Table 169. Liconsa SA Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Liconsa SA Tianeptine Product
Table 171. Liconsa SA Recent Development
Table 172. Mylan Company Information
Table 173. Mylan Introduction and Business Overview
Table 174. Mylan Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 175. Mylan Tianeptine Product
Table 176. Mylan Recent Development
Table 177. Adamed Company Information
Table 178. Adamed Introduction and Business Overview
Table 179. Adamed Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 180. Adamed Tianeptine Product
Table 181. Adamed Recent Development
Table 182. Neuraxpharm Arzneimittel Company Information
Table 183. Neuraxpharm Arzneimittel Introduction and Business Overview
Table 184. Neuraxpharm Arzneimittel Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 185. Neuraxpharm Arzneimittel Tianeptine Product
Table 186. Neuraxpharm Arzneimittel Recent Development
Table 187. Grupo Insud Company Information
Table 188. Grupo Insud Introduction and Business Overview
Table 189. Grupo Insud Tianeptine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 190. Grupo Insud Tianeptine Product
Table 191. Grupo Insud Recent Development
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Tianeptine Market Trends
Table 195. Tianeptine Market Drivers
Table 196. Tianeptine Market Challenges
Table 197. Tianeptine Market Restraints
Table 198. Tianeptine Distributors List
Table 199. Tianeptine Downstream Customers
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Tianeptine Product Picture
Figure 2. Global Tianeptine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Tianeptine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Tianeptine Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Patent
Figure 6. Global Patent Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Generic
Figure 8. Global Generic Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Tianeptine Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Tianeptine Sales Market Share by Type in 2022 & 2034
Figure 11. North America Tianeptine Sales Market Share in Volume by Type in 2022
Figure 12. North America Tianeptine Sales Market Share in Value by Type in 2022
Figure 13. Europe Tianeptine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Tianeptine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Tianeptine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Tianeptine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Tianeptine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Tianeptine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Tianeptine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Tianeptine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Tianeptine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Tianeptine Revenue in 2022
Figure 23. Tianeptine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Depression and Anxiety
Figure 25. Global Depression and Anxiety Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Irritable Bowel Syndrome
Figure 27. Global Irritable Bowel Syndrome Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Global Tianeptine Sales by Application (2024-2034) & (US$ Million)
Figure 29. Global Tianeptine Sales Market Share by Application in 2022 & 2034
Figure 30. North America Tianeptine Sales Market Share in Volume by Application in 2022
Figure 31. North America Tianeptine Sales Market Share in Value by Application in 2022
Figure 32. Europe Tianeptine Sales Market Share in Volume by Application in 2022
Figure 33. Europe Tianeptine Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Tianeptine Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Tianeptine Sales Market Share in Value by Application in 2022
Figure 36. Latin America Tianeptine Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Tianeptine Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Tianeptine Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Tianeptine Manufacturing Cost Structure
Figure 41. Tianeptine Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed